lophos_logo.jpg
Lophos Pharmaceuticals Corp. Enters Into Letter of Intent to Acquire the Assets of Magicactus.com
06 mai 2024 07h59 HE | Lophos Holdings Inc.
NAPANEE, Ontario, May 06, 2024 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. ("Lophos", or the "Company") (CSE:MESC) is pleased to announce that its wholly-owned subsidiary, Lophos Pharmaceuticals Corp....
lophos_logo.jpg
Lophos Pharmaceuticals Corp. Commences Peyote Research Protocol
02 mai 2024 08h00 HE | Lophos Holdings Inc.
NAPANEE, Ontario, May 02, 2024 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. ("Lophos", or the "Company") (CSE:MESC) is pleased to announce the official commencement of its first research protocol under...
lophos_logo.jpg
Lophos Pharmaceuticals Corp. Expands Peyote Cultivation with the Successful Planting of 3,000 Seeds
25 avr. 2024 08h00 HE | Lophos Holdings Inc.
VANCOUVER, British Columbia, April 25, 2024 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. (CSE: MESC) ("Lophos" or the "Company") proudly announces a milestone accomplishment from its subsidiary, Lophos...
lophos_logo.jpg
Lophos Pharmaceuticals’ Licensed Site Celebrates Successful Building Occupancy
17 avr. 2024 08h00 HE | Lophos Holdings Inc.
VANCOUVER, British Columbia, April 17, 2024 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. (“Lophos” or the “Company”) (CSE:MESC) is delighted to announce the successful receipt of building occupancy for...
lophos_logo.jpg
ThreeD Capital Inc. and Lophos Holdings Inc. Announce Strategic Partnership
15 avr. 2024 08h00 HE | Lophos Holdings Inc.
VANCOUVER, British Columbia, April 15, 2024 (GLOBE NEWSWIRE) -- ThreeD Capital Inc. ("ThreeD"), a publicly traded Canadian-based venture capital firm focused on opportunistic investments in...
lophos_logo.jpg
Lophos Holdings Inc. Celebrates Successful Conclusion of Inaugural Annual General Meeting, Confirms Board Members and Stock Options Plan
28 mars 2024 18h43 HE | Lophos Holdings Inc.
VANCOUVER, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. (CSE: MESC) ("Lophos" or the "Company") is pleased to announce all matters presented for approval at the annual...
lophos_logo.jpg
Lophos Pharmaceuticals Partners With Carmichael Engineering Ltd. for HVAC Project, Anticipates Expedited Building Occupancy
05 mars 2024 07h55 HE | Lophos Holdings Inc.
NAPANEE, Ontario, March 05, 2024 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. ("Lophos" or the "Company") (CSE:MESC) is pleased to announce its subsidiary, Lophos Pharmaceuticals Corp., has selected...
lophos_logo.jpg
Lophos Confirms Appearance at Benzinga Capital Conference in Hollywood, Florida and Finalizes Annual General Meeting
28 févr. 2024 08h00 HE | Lophos Holdings Inc.
NAPANEE, Ontario, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. ("Lophos", or the "Company") (CSE:MESC) is thrilled to announce its wholly-owned subsidiary, Lophos Pharmaceuticals Corp.,...
lophos_logo.jpg
Lophos Pharmaceuticals Corp. Finalizes the Development of a New Research Protocol for Lophophora Williamsii (Peyote)
14 févr. 2024 09h04 HE | Lophos Holdings Inc.
NAPANEE, Ontario, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. ("Lophos", or the "Company") (CSE:MESC) is thrilled to provide further insights into the accomplishments of its wholly-owned...
lophos_logo.jpg
Lophos Pharmaceuticals Corp. Finalizes the Development of a New Synthetic Mescaline Protocol
08 févr. 2024 08h00 HE | Lophos Holdings Inc.
NAPANEE, Ontario, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. ("Lophos", or the "Company") (CSE:MESC) is thrilled to provide further insights into the accomplishments of its wholly-owned...